Methodology of a new inflammatory arthritis registry: TReasure

Background/aim: The TReasure registry, created in 2017, is an observational multicenter cohort that includes inflammatory arthritispatients. This article reviews the methodology and objectives of the TReasure registry established to collect data from rheumatoidarthritis (RA) and spondyloarthritis (SpA) patients.Methodology: Fifteen rheumatology centers in Turkey will contribute data to the TReasure database. The actual proprietor of thedatabase is the Hacettepe Rheumatology Association (HRD) and Hacettepe Financial Enterprises. Pharmaceutical companies thatoperate in Turkey (in alphabetical or er), Abbvie, Amgen, BMS, Celltrion Healthcare, Novartis, Pfizer, Roche, and UCB, support theTReasure registry. TReasure is a web-based database to which users connect through a URL (https://www.trials-network.org/treasure)with their unique identifier and passwords provided for data entry and access. TReasure records demographic and clinical features,comorbidities, radiology and laboratory results, measures of disease activity, and treatment data.Discussion: TReasure will provide us with various types of data, such as a cross-sectional view of the current nationwide status of thepatients currently receiving these treatments, and retrospective data as much as allowed by the participating centers’ records. Finally, ahigh-quality prospective dataset will be built over the ensuing years from patients with a new diagnosis of RA or SpA.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, Cöster L, Jacobsson LT, Lindblad S et al. Antitumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 2009; 68: 648-653.
Lapadula G, Ferraccioli G, Ferri C, Punzi L, Trotta F. GISEA: An Italian biological agents registry in rheumatology. Reumatismo 2011; 63: 155-164.
Mariette X, Gottenberg JE, Ravaud P, Combe B. Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology (Oxford) 2011; 50: 222-229.
Strangfeld A, Eveslage M, Schneider M, Bergerhausen HJ, Klopsch T, Zink A, Listing J. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 2011; 70: 1914- 1920.
de la Vega M, da Silveira de Carvalho HM, Ventura Rios L, Goycochea Robles MV, Casado GC. The importance of rheumatology biologic registries in Latin America. Rheumatol Int 2013; 33: 827-835.
Ibfelt EH, Jensen DV, Hetland ML. The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO. Clin Epidemiol 2016; 8: 737-742.
Mercer LK, Galloway JB, Lunt M, Davies R, Low AL, Dixon WG, Watson KD; BSRBR Control Centre Consortium, Symmons DP, Hyrich KL. Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 2017; 76: 497-503.
Strand V, Miller P, Williams SA, Saunders K, Grant S, Kremer J. Discontinuation of biologic therapy in rheumatoid arthritis: analysis from the Corrona RA Registry. Rheumatol Ther 2017; 4: 489-502.
Ruderman EM. Overview of safety of non-biologic and biologic DMARDs. Rheumatology (Oxford) 2012; 51 (Suppl. 6): vi37-43.
Erden A, Kılıç L, Karadağ Ö, Akdoğan A, Bilgen ŞA, Kıraz S, Ertenli İ, Kalyoncu U. Ankilozan spondilit hastalarında golimumab kullanımı: HÜR-BİO/Spondiloartrit gerçek yaşam deneyimi. RAED Dergisi 2015; 7: 6-9 (in Turkish).
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-2581.
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-368.
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (Part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-783.
Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70: 25-31.
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977; 237: 2613-2614.
Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006; 54: 569-578.
Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis International Society (ASAS). Ann Rheum Dis 2009; 68: 784- 788.
Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008; 59: 686-691.
Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003; 30: 167-178.
Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48.
Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: 796-806.
Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 1999; 38: 878-882.
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-2285.
Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D; Assessment of SpondyloArthritis International Society. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 18-24.
Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-559.
Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, Maksymowych WP, Marzo-Ortega H, Reveille J, Stebbings S et al. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 2015; 74: 830-835.
Salaffi F, Di Carlo M, Carotti M, Farah S, Gutierrez M. The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touchscreen administration versus the paper-and-pencil version. Ther Clin Risk Manag 2016; 12: 631-642.
Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.

APA	KALYONCU U, TAŞCILAR E, ERTENLİ A, DALKILIÇ H, BES C, KÜÇÜKŞAHİN O, KAŞİFOĞLU T, ALPAY KANITEZ N, emmungil h, Kimyon G, YAŞAR BİLGE N, Akar S, ATAGÜNDÜZ M, Koca S, ATEŞ A, YAZISIZ V, terzioglu e, Ersozlu E, AYDIN TUFAN M, Cinar M, mercan r, ŞAHİN A, Erten Ş, PEHLİVAN Y, YILMAZ S, KELEŞOĞLU DİNÇER A, Gerçik Ö, COŞKUN B, Yağız B, Kaymaz-Tahra S, Aksoy A, KARADAĞ Ö, Kılıç L, KİRAZ S (2018). Methodology of a new inflammatory arthritis registry: TReasure. , 856 - 861. 10.3906/sag-1807-200
Chicago	KALYONCU Umut,TAŞCILAR Etem Koray,ERTENLİ Ali İhsan,DALKILIÇ Hüseyin Ediz,BES Cemal,KÜÇÜKŞAHİN Orhan,KAŞİFOĞLU Timuçin,ALPAY KANITEZ NİLÜFER,emmungil hakan,Kimyon Gezmiş,YAŞAR BİLGE Nazife Şule,Akar Servet,ATAGÜNDÜZ Mehmet Pamir,Koca Suleyman Serdar,ATEŞ Aşkın,YAZISIZ VELİ,terzioglu ender,Ersozlu Emine Duygu,AYDIN TUFAN Müge,Cinar Muhammet,mercan ridvan,ŞAHİN Ali,Erten Şükran,PEHLİVAN Yavuz,YILMAZ Sedat,KELEŞOĞLU DİNÇER AYŞE BAHAR,Gerçik Önay,COŞKUN Belkıs Nihan,Yağız Burcu,Kaymaz-Tahra Sema,Aksoy Aysun,KARADAĞ ÖMER,Kılıç Levent,KİRAZ Sedat Methodology of a new inflammatory arthritis registry: TReasure. (2018): 856 - 861. 10.3906/sag-1807-200
MLA	KALYONCU Umut,TAŞCILAR Etem Koray,ERTENLİ Ali İhsan,DALKILIÇ Hüseyin Ediz,BES Cemal,KÜÇÜKŞAHİN Orhan,KAŞİFOĞLU Timuçin,ALPAY KANITEZ NİLÜFER,emmungil hakan,Kimyon Gezmiş,YAŞAR BİLGE Nazife Şule,Akar Servet,ATAGÜNDÜZ Mehmet Pamir,Koca Suleyman Serdar,ATEŞ Aşkın,YAZISIZ VELİ,terzioglu ender,Ersozlu Emine Duygu,AYDIN TUFAN Müge,Cinar Muhammet,mercan ridvan,ŞAHİN Ali,Erten Şükran,PEHLİVAN Yavuz,YILMAZ Sedat,KELEŞOĞLU DİNÇER AYŞE BAHAR,Gerçik Önay,COŞKUN Belkıs Nihan,Yağız Burcu,Kaymaz-Tahra Sema,Aksoy Aysun,KARADAĞ ÖMER,Kılıç Levent,KİRAZ Sedat Methodology of a new inflammatory arthritis registry: TReasure. , 2018, ss.856 - 861. 10.3906/sag-1807-200
AMA	KALYONCU U,TAŞCILAR E,ERTENLİ A,DALKILIÇ H,BES C,KÜÇÜKŞAHİN O,KAŞİFOĞLU T,ALPAY KANITEZ N,emmungil h,Kimyon G,YAŞAR BİLGE N,Akar S,ATAGÜNDÜZ M,Koca S,ATEŞ A,YAZISIZ V,terzioglu e,Ersozlu E,AYDIN TUFAN M,Cinar M,mercan r,ŞAHİN A,Erten Ş,PEHLİVAN Y,YILMAZ S,KELEŞOĞLU DİNÇER A,Gerçik Ö,COŞKUN B,Yağız B,Kaymaz-Tahra S,Aksoy A,KARADAĞ Ö,Kılıç L,KİRAZ S Methodology of a new inflammatory arthritis registry: TReasure. . 2018; 856 - 861. 10.3906/sag-1807-200
Vancouver	KALYONCU U,TAŞCILAR E,ERTENLİ A,DALKILIÇ H,BES C,KÜÇÜKŞAHİN O,KAŞİFOĞLU T,ALPAY KANITEZ N,emmungil h,Kimyon G,YAŞAR BİLGE N,Akar S,ATAGÜNDÜZ M,Koca S,ATEŞ A,YAZISIZ V,terzioglu e,Ersozlu E,AYDIN TUFAN M,Cinar M,mercan r,ŞAHİN A,Erten Ş,PEHLİVAN Y,YILMAZ S,KELEŞOĞLU DİNÇER A,Gerçik Ö,COŞKUN B,Yağız B,Kaymaz-Tahra S,Aksoy A,KARADAĞ Ö,Kılıç L,KİRAZ S Methodology of a new inflammatory arthritis registry: TReasure. . 2018; 856 - 861. 10.3906/sag-1807-200
IEEE	KALYONCU U,TAŞCILAR E,ERTENLİ A,DALKILIÇ H,BES C,KÜÇÜKŞAHİN O,KAŞİFOĞLU T,ALPAY KANITEZ N,emmungil h,Kimyon G,YAŞAR BİLGE N,Akar S,ATAGÜNDÜZ M,Koca S,ATEŞ A,YAZISIZ V,terzioglu e,Ersozlu E,AYDIN TUFAN M,Cinar M,mercan r,ŞAHİN A,Erten Ş,PEHLİVAN Y,YILMAZ S,KELEŞOĞLU DİNÇER A,Gerçik Ö,COŞKUN B,Yağız B,Kaymaz-Tahra S,Aksoy A,KARADAĞ Ö,Kılıç L,KİRAZ S "Methodology of a new inflammatory arthritis registry: TReasure." , ss.856 - 861, 2018. 10.3906/sag-1807-200
ISNAD	KALYONCU, Umut vd. "Methodology of a new inflammatory arthritis registry: TReasure". (2018), 856-861. https://doi.org/10.3906/sag-1807-200

APA	KALYONCU U, TAŞCILAR E, ERTENLİ A, DALKILIÇ H, BES C, KÜÇÜKŞAHİN O, KAŞİFOĞLU T, ALPAY KANITEZ N, emmungil h, Kimyon G, YAŞAR BİLGE N, Akar S, ATAGÜNDÜZ M, Koca S, ATEŞ A, YAZISIZ V, terzioglu e, Ersozlu E, AYDIN TUFAN M, Cinar M, mercan r, ŞAHİN A, Erten Ş, PEHLİVAN Y, YILMAZ S, KELEŞOĞLU DİNÇER A, Gerçik Ö, COŞKUN B, Yağız B, Kaymaz-Tahra S, Aksoy A, KARADAĞ Ö, Kılıç L, KİRAZ S (2018). Methodology of a new inflammatory arthritis registry: TReasure. Turkish Journal of Medical Sciences, 48(4), 856 - 861. 10.3906/sag-1807-200
Chicago	KALYONCU Umut,TAŞCILAR Etem Koray,ERTENLİ Ali İhsan,DALKILIÇ Hüseyin Ediz,BES Cemal,KÜÇÜKŞAHİN Orhan,KAŞİFOĞLU Timuçin,ALPAY KANITEZ NİLÜFER,emmungil hakan,Kimyon Gezmiş,YAŞAR BİLGE Nazife Şule,Akar Servet,ATAGÜNDÜZ Mehmet Pamir,Koca Suleyman Serdar,ATEŞ Aşkın,YAZISIZ VELİ,terzioglu ender,Ersozlu Emine Duygu,AYDIN TUFAN Müge,Cinar Muhammet,mercan ridvan,ŞAHİN Ali,Erten Şükran,PEHLİVAN Yavuz,YILMAZ Sedat,KELEŞOĞLU DİNÇER AYŞE BAHAR,Gerçik Önay,COŞKUN Belkıs Nihan,Yağız Burcu,Kaymaz-Tahra Sema,Aksoy Aysun,KARADAĞ ÖMER,Kılıç Levent,KİRAZ Sedat Methodology of a new inflammatory arthritis registry: TReasure. Turkish Journal of Medical Sciences 48, no.4 (2018): 856 - 861. 10.3906/sag-1807-200
MLA	KALYONCU Umut,TAŞCILAR Etem Koray,ERTENLİ Ali İhsan,DALKILIÇ Hüseyin Ediz,BES Cemal,KÜÇÜKŞAHİN Orhan,KAŞİFOĞLU Timuçin,ALPAY KANITEZ NİLÜFER,emmungil hakan,Kimyon Gezmiş,YAŞAR BİLGE Nazife Şule,Akar Servet,ATAGÜNDÜZ Mehmet Pamir,Koca Suleyman Serdar,ATEŞ Aşkın,YAZISIZ VELİ,terzioglu ender,Ersozlu Emine Duygu,AYDIN TUFAN Müge,Cinar Muhammet,mercan ridvan,ŞAHİN Ali,Erten Şükran,PEHLİVAN Yavuz,YILMAZ Sedat,KELEŞOĞLU DİNÇER AYŞE BAHAR,Gerçik Önay,COŞKUN Belkıs Nihan,Yağız Burcu,Kaymaz-Tahra Sema,Aksoy Aysun,KARADAĞ ÖMER,Kılıç Levent,KİRAZ Sedat Methodology of a new inflammatory arthritis registry: TReasure. Turkish Journal of Medical Sciences, vol.48, no.4, 2018, ss.856 - 861. 10.3906/sag-1807-200
AMA	KALYONCU U,TAŞCILAR E,ERTENLİ A,DALKILIÇ H,BES C,KÜÇÜKŞAHİN O,KAŞİFOĞLU T,ALPAY KANITEZ N,emmungil h,Kimyon G,YAŞAR BİLGE N,Akar S,ATAGÜNDÜZ M,Koca S,ATEŞ A,YAZISIZ V,terzioglu e,Ersozlu E,AYDIN TUFAN M,Cinar M,mercan r,ŞAHİN A,Erten Ş,PEHLİVAN Y,YILMAZ S,KELEŞOĞLU DİNÇER A,Gerçik Ö,COŞKUN B,Yağız B,Kaymaz-Tahra S,Aksoy A,KARADAĞ Ö,Kılıç L,KİRAZ S Methodology of a new inflammatory arthritis registry: TReasure. Turkish Journal of Medical Sciences. 2018; 48(4): 856 - 861. 10.3906/sag-1807-200
Vancouver	KALYONCU U,TAŞCILAR E,ERTENLİ A,DALKILIÇ H,BES C,KÜÇÜKŞAHİN O,KAŞİFOĞLU T,ALPAY KANITEZ N,emmungil h,Kimyon G,YAŞAR BİLGE N,Akar S,ATAGÜNDÜZ M,Koca S,ATEŞ A,YAZISIZ V,terzioglu e,Ersozlu E,AYDIN TUFAN M,Cinar M,mercan r,ŞAHİN A,Erten Ş,PEHLİVAN Y,YILMAZ S,KELEŞOĞLU DİNÇER A,Gerçik Ö,COŞKUN B,Yağız B,Kaymaz-Tahra S,Aksoy A,KARADAĞ Ö,Kılıç L,KİRAZ S Methodology of a new inflammatory arthritis registry: TReasure. Turkish Journal of Medical Sciences. 2018; 48(4): 856 - 861. 10.3906/sag-1807-200
IEEE	KALYONCU U,TAŞCILAR E,ERTENLİ A,DALKILIÇ H,BES C,KÜÇÜKŞAHİN O,KAŞİFOĞLU T,ALPAY KANITEZ N,emmungil h,Kimyon G,YAŞAR BİLGE N,Akar S,ATAGÜNDÜZ M,Koca S,ATEŞ A,YAZISIZ V,terzioglu e,Ersozlu E,AYDIN TUFAN M,Cinar M,mercan r,ŞAHİN A,Erten Ş,PEHLİVAN Y,YILMAZ S,KELEŞOĞLU DİNÇER A,Gerçik Ö,COŞKUN B,Yağız B,Kaymaz-Tahra S,Aksoy A,KARADAĞ Ö,Kılıç L,KİRAZ S "Methodology of a new inflammatory arthritis registry: TReasure." Turkish Journal of Medical Sciences, 48, ss.856 - 861, 2018. 10.3906/sag-1807-200
ISNAD	KALYONCU, Umut vd. "Methodology of a new inflammatory arthritis registry: TReasure". Turkish Journal of Medical Sciences 48/4 (2018), 856-861. https://doi.org/10.3906/sag-1807-200